|
Characteristics
|
Training cohort (N = 48)
|
Validation cohort (N = 148)
|
|---|
|
Age, year
|
|
< 60
|
27 (56.25%)
|
79 (53.38%)
|
|
≥ 60
|
21 (43.75%)
|
69 (46.62%)
|
|
Sex
|
|
Male
|
43 (89.58%)
|
116 (78.38%)
|
|
Female
|
5 (10.42%)
|
32 (21.62%)
|
|
Smoking history
|
|
Yes
|
33 (68.75%)
|
92 (62.16%)
|
|
No
|
15 (31.25%)
|
56 (37.84%)
|
|
SCLC staging
|
|
I
|
8 (16.67%)
|
54 (36.49%)
|
|
II
|
8 (16.67%)
|
48 (32.43%)
|
|
III
|
31 (62.50%)
|
46 (31.08%)
|
|
IV
|
1 (2.08%)
|
0 (0.00%)
|
|
OS state
|
|
Alive
|
25 (52.08%)
|
68 (45.95%)
|
|
Death
|
23 (47.92%)
|
80 (54.05%)
|
- SCLC small cell lung cancer; OS overall survival
